Bococizumab is a cutting-edge anti-PCSK9 antibody efficiently developed to treat hypercholesterolemia. It therapeutic agent functions through the PCSK9 protein, a key regulator of cholesterol levels. By blocking the https://tedrilj214503.wikitelevisions.com/9314269/bococizumab_a_novel_anti_pcsk9_antibody_for_hypercholesterolemia